| Direct Competitor Comparison | |
|---|
| CYCC | AZN | PVT1 | JNJ | Industry |
|---|
| Market Cap: | 33.08M | 64.45B | N/A | 247.43B | 71.76B |
|---|
| Employees: | 17 | 51,700 | 10,7301 | 127,600 | 450.00 |
|---|
| Qtrly Rev Growth (yoy): | 0.32 | -0.13 | N/A | 0.09 | 0.27 |
|---|
| Revenue (ttm):
| 281.00k | 27.01B | 7.88B1 | 68.59B | 13.93B |
|---|
| Gross Margin (ttm): | 1.00 | 0.81 | N/A | 0.68 | 0.72 |
|---|
| EBITDA (ttm): | -15.98M | 11.09B | N/A | 21.74B | 1.51B |
|---|
| Operating Margin (ttm):
| -57.08 | 0.33 | N/A | 0.26 | 0.13 |
|---|
| Net Income (ttm): | -23.09M | 5.68B | 711.10M1 | 10.44B | N/A |
|---|
| EPS (ttm): | -2.54 | 4.52 | N/A | 3.68 | 0.61 |
|---|
| P/E (ttm): | N/A | 11.40 | N/A | 23.92 | 18.43 |
|---|
| PEG (5 yr expected): | N/A | -1.02 | N/A | 2.55 | 1.51 |
|---|
| P/S (ttm): | 117.72 | 2.39 | N/A | 3.61 | 3.64 |
|---|
|
| AZN = AstraZeneca PLC | | Pvt1 = Eisai Co., Ltd. | | JNJ = Johnson & Johnson | | Industry = Biotechnology | | 1 = As of 2012 |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.63 | 0.00 | 79.22B | 17.88 |
|---|
| Genentech, Inc. | "Private" |
|---|
| Biogen Idec Inc. | BIIB | 226.85 | 0.00 | 53.85B | 36.00 |
|---|
| Genzyme Corporation | "Private" |
|---|
| Merck Serono S.A. | "Private" |
|---|
| Gilead Sciences Inc. | GILD | 56.30 | 0.00 | 85.88B | 31.52 |
|---|
| MedImmune, L.L.C. | "Private" |
|---|
| Life Technologies Corporation | LIFE | 73.54 | 0.00 | 12.65B | 31.13 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 40.23 | 0.00 | 34.28B | 20.08 |
|---|
| Sandoz International GmbH | "Private" |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 125.50 | 0.00 | 16.03B | N/A |
|---|
| Ranbaxy Laboratories Limited | "Private" |
|---|
| Mylan, Inc. | MYL | 31.40 | 0.00 | 11.97B | 20.98 |
|---|
| Pfizer Inc. | PFE | 28.96 | 0.00 | 205.42B | 13.86 |
|---|
| Johnson & Johnson | JNJ | 88.09 | 0.00 | 247.43B | 23.92 |
|---|
| GlaxoSmithKline plc | GSK | 52.22 | 0.00 | 126.48B | 19.09 |
|---|
| Sanofi | SNY | 54.50 | 0.00 | 144.25B | 26.86 |
|---|
| Novartis AG | NVS | 74.15 | 0.00 | 182.20B | 18.82 |
|---|
| Roche Holding AG | RHHBY | 63.13 | 0.00 | 214.26B | 21.13 |
|---|
| AstraZeneca PLC | AZN | 51.56 | 0.00 | 64.45B | 11.40 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 36.59 | 0.00 | 57.04B | 11.15 |
|---|
| Bristol-Myers Squibb Company | BMY | 43.30 | 0.00 | 71.12B | 49.04 |
|---|
|
| News on Direct Competitors | |
|---|
- AZN
- Statin Users May Have a Reason to Rejoice After This Data at Motley Fool Sun 12:05pm
- AZN
- Pick Your Poison: Overweight or High Cholesterol at Motley Fool Sun 11:00am
- JNJ
- Investment Ideas in the Expanding Wound Care Market Accesswire Fri, May 17
- JNJ
- StockCall Scrutinizes PFE, MRK, JNJ, ABBV, and ZGNX Accesswire Wed, May 15
- AZN
- GSK, AZN, KERX, and RPTP Early Briefing and Review Accesswire Thu, May 2
- JNJ
- Traders’ Favorite: National Bank of Greece, EMC Corporation, BioCryst Pharmaceuticals Accesswire Mon, Apr 8
- AZN
- Sizzling Stocks: AstraZeneca plc, Zynga Inc, Rigel Pharmaceuticals Accesswire Fri, Apr 5
- AZN
- Sizzling Movers: Arena Pharmaceuticals, AstraZeneca plc, Google Inc Accesswire Fri, Mar 22
- JNJ
- Red Bull's openness on feces threat could pay off Reuters Fri, Mar 15
- JNJ
- News Buzz: Yum! Brands, American International Group Inc, Johnson & Johnson Accesswire Tue, Mar 12
All headlines for these symbols... Currency in USD. | |
|